Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery

Jee BC, Byung Chul Jee, Lee JY, Joong Yeup Lee, Chang Suk Suh, Suh CS, Seok Hyun Kim, Kim SH, Choi YM, Young Min Choi, Moon SY, Shin Yong Moon
Fertility and sterility · 2008 · vol. 91(1) , pp. 40–45 · doi:10.1016/j.fertnstert.2007.11.027 · PMID:18377899 · W2005219012
article OA: closed CC0 ⤵ 67 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated the effect of GnRH agonist treatment on the recurrence rate of ovarian endometriomas following conservative laparoscopic surgery.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo analyze the influence of postoperative GnRH agonist treatment on disease recurrence after conservative laparoscopic surgery for ovarian endometriomas according to duration of the treatment.DesignRetrospective cohort study.SettingUniversity hospital.Patient(s)One hundred nine consecutive premenopausal women who underwent conservative laparoscopic surgery for ovarian endometriomas (endometriosis stage III/IV) were enrolled in the study. The patients were divided into four treatment groups: expectant management (n = 37) and GnRH agonist therapy for 3 (n = 28), 4 (n = 21), and 6 months (n = 23).Intervention(s)None.Main outcome measure(s)An ultrasound confirmed recurrence of ovarian endometriomas.Result(s)The overall crude recurrence rate was 16.5% after follow-up for an average of 20.1 months. The crude recurrence and the cumulative probabilities of disease recurrence at 24/36 months tended to be lower in patients who received a GnRH agonist for 6 months (4.3%, 5.3%/5.3%) compared with those who received it for 3 months (17.9%, 12.5%/25.0%) and 4 months (28.6%, 18.9%/39.2%) and patients with expectant management (16.2%, 22.4%/37.9%). However, the differences did not reach statistical significance.Conclusion(s)Treatment with GnRH agonist for six months had a beneficial impact on the recurrence rate after conservative laparoscopic surgery for ovarian endometriomas.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Gonadotropin-Releasing Hormone Laparoscopy Recurrence Combined Modality Therapy Endometriosis Female Follow-Up Studies Gonadotropin-Releasing Hormone Gynecologic Surgical Procedures Humans Korea Probability Time Factors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (43)

Cited by (50)

Source provenance

europepmc
last seen: 2026-07-29T06:27:48.050232+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:14:36.758325+00:00
License: CC0 · commercial use OK